Week 1
Lecture 1. Setting the stage: health care sector/health economics/not for profit organizations. Is health care special? Physicians’ behavior.  Supplier induced demand. Hospital markets.
Lecture 2. Insurance theory. Prospect theory. Problems with private health insurance. Social insurance. Moral hazard.

Week 2
Lecture 1. Managed competition.
Lecture 2. Quality of care measurement. Pay for performance. Benchmarking.

Week 3
Lecture 1. Cost benefit analysis in health care.Valuation of non-market goods in health care.
Lecture 2. Cost-effectiveness analysis/Cost measures/Cost of illness studies/ transferability of results/clinical trials/ natural units.

Week 4
Lecture 1. Outcome measures in health care/Who’s values count? Coping. WTP. QALY.
Lecture 2. ICERs and other decision rules + how to determine what types of care can be funded/included in basic package. Alternative approaches versus CBA.

Week 5
Lecture 1. Equity. Equity in outcome measures.
Lecture 2. Health production/addiction models/health bads.

Week 6
Lecture 1. Pharmaceutical Policy.
Lecture 2. Guest lecture combined with seminar. Stam/Van Kleef.

Week 7
Lecture 1. Long term care/Baumol/Nursing homes.
Lecture 2. Economics of informal care.

Week 8
Lecture 1. International comparison of health systems.
Lecture 2. Developing countries (generalized CEA of the WHO).

Week 9
Student presentations.

Week 10
Student presentations.

Bibliography
BERG, M. i d’altres. “Feasibility first: Developing public performance indicators on patient safety and clinical effectiveness for Dutch hospitals”. Health Policy, 75. 2005. Pàg. 59-73.
CUTLER, D. Your money or your life. Oxford University Press, 2004.
GONZÁLEZ LÓPEZ-VALCÁRCEL, B. i d’altres. “Mejorando la efectividad de las intervenciones públicas sobre la salud. Informe Sespas 2008”. Gaceta Sanitaria, 22. 2008. Monografico 2.
FOLLAND, S.; GOODMAN, A.; STANO, M. The economics of health and health care. 3a ed. Prentice Hall, 2001.
LAPPÉ, J. I d’altres. “Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program”. Annals of Internal Medicine, 141. 2004. Pàg. 446-453.
LÓPEZ, G. (dir.). El interfaz público-privado en Sanidad. Barcelona: Masson, 2002.
MENEU, R.; PEIRÓ, S. (dir.). Elementos para la gestión de la prescripción y la prestación farmacéutica. Barcelona: Masson, 2004.
NEWHOUSE, J. Free for all?. Harvard University Press, 1993.
ORTÚN, V. (dir.). Gestión clínica y sanitaria. De la práctica diaria a la academia, ida y vuelta. Barcelona: Masson, 2003.
PHELPS, C. Health Economics. Nova York: Harper Collins, 1992.
PINTO, J.L.; VÁZQUEZ, M.X.; LÁZARO, A.; MARTÍNEZ, J.E.; Análisis coste-beneficio en la salud: métodos de valoración y aplicaciones. Barcelona: Masson, 2003.
PUIG, J.; LÓPEZ, G.; ORTÚN, V. (dir.). ¿Más recursos para la salud?. Barcelona: Masson, 2004.
ROSE, G. “Sick individuals and sick populations”. International Journal of Epidemiology 14. 1985. Pàg. 32-38.
ROSE, G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.
SEN, A. “Mortality as an indicator of economic success and failure”. The Economic Journal, 108.1998. Pàg. 1-25.
VAN DE VEN, i d’altres. “Health-adjusted premium subsidies in the Netherlands”. Health Affairs 23 (3). 2004. Pàg. 45-55.
WORLD BANK. World development report 2004. Making services work for poor people. World Bank and Oxford University Press, 2004.

Useful links
Asociación de Economía de la Salud www.aes.es
Centre de Recerca en Economia i Salut www.upf.edu/cres/